Jigar Chaudhary

Jigar Chaudhary is the Editor-in-Chief at UrviumAI, where he oversees coverage of artificial intelligence news, tools, and in-depth studies. With over 5 years of experience analyzing AI and robotics, he focuses on maintaining high editorial standards, accurate reporting, and clear explanations to help readers understand how AI is shaping the future.

Mustafa Suleyman’s Warning: The Peril of Seemingly Conscious AI

A Stellar Alert in the AI Universe: 🌌 On August 20, 2025, Microsoft AI CEO Mustafa Suleyman published an essay on Seemingly Conscious AI (SCAI), warning that AI mimicking sentience could destabilize society and AI development, per mustafa-suleyman.ai. In the $24.5B AI market, his call to avoid anthropomorphizing AI sparks debate against Anthropic’s model welfare

Mustafa Suleyman’s Warning: The Peril of Seemingly Conscious AI Read More »

Alibaba’s Qwen-Image-Edit

Alibaba’s Qwen-Image-Edit: A Cosmic Leap in AI Image Editing

A Stellar Breakthrough in Visual Creativity: 🌌 Alibaba’s Qwen team launched Qwen-Image-Edit on August 18, 2025, a 20B parameter open-source model revolutionizing the $10B digital imaging market. With pixel-perfect edits, style transformations, and bilingual text capabilities, it outshines rivals like Seedream and FLUX.1, per Alibaba’s benchmarks. Let’s blast off into this cosmic innovation and its

Alibaba’s Qwen-Image-Edit: A Cosmic Leap in AI Image Editing Read More »

KAIST’s BInD AI

KAIST’s BInD AI: A Cosmic Leap in Cancer Drug Design

A Stellar Breakthrough in Drug Discovery: 🌌 Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have unveiled BInD, a revolutionary AI diffusion model that designs cancer drugs from scratch, announced in August 2025. In the $150B global drug discovery market, BInD’s ability to craft precise, safe, and manufacturable cancer therapies without prior

KAIST’s BInD AI: A Cosmic Leap in Cancer Drug Design Read More »

Scroll to Top